-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Bone Marrow Failure Syndromes Sessions

Friday, December 6, 2024

top

7:00 AM-10:00 AM


MDS 2024: Let’s Overcome the Challenges  
Friday Satellite Symposia

Saturday, December 7, 2024

top

8:00 AM-9:00 AM


Nonmalignant Hematologic Disorders Forum: Deeper Dive Into PNH, aHUS, and ITP  
Industry Forums

9:00 AM-7:30 PM


Poster Session I - Viewing  
Events

9:30 AM-11:00 AM


508. Bone Marrow Failure: Acquired: Biological Findings Associated with the Pathophysiology and Outcomes of Aplastic Anemia and PNH  
Oral and Poster Abstracts

11:15 AM-12:15 PM


Career Development Lunch
Trainee Activities and Services

11:30 AM-12:30 PM


Choosing a Different Approach: Clinical and Nonclinical Factors for Adults with PNH on FABHALTA  
Product Theaters

2:00 PM-3:30 PM


503. Clonal Hematopoiesis, Aging, and Inflammation: Mechanisms of Hematopoietic Aging and Inflammation  
Oral and Poster Abstracts


509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Disease Modeling and Molecular Mechanisms  
Oral and Poster Abstracts

3:30 PM-3:45 PM


The spatial organization of surface proteins of single cells in myelodysplastic syndrome for diagnostics and drug target discovery by Molecular Pixelation (MPX)  
Company Showcases

4:00 PM-5:30 PM


508. Bone Marrow Failure: Acquired: Emerging Data in the Treatment of Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria  
Oral and Poster Abstracts


636. Myelodysplastic Syndromes: Basic and Translational: Disease Mechanisms and Therapeutic Vulnerabilities in Molecular Genetic Subtypes of MDS  
Oral and Poster Abstracts


721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Optimizing Outcomes in Pediatric, Adolescent and Young Adult Patients  
Oral and Poster Abstracts

5:30 PM-7:30 PM


Poster Session I - Presentations (for in-person participants)  
Events


101. Red Cells and Erythropoiesis, Excluding Iron: Poster I  
Oral and Poster Abstracts


301. Platelets and Megakaryocytes: Basic and Translational: Poster I  
Oral and Poster Abstracts


501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Poster I  
Oral and Poster Abstracts


503. Clonal Hematopoiesis, Aging, and Inflammation: Poster I  
Oral and Poster Abstracts


506. Bone Marrow Microenvironment: Poster I  
Oral and Poster Abstracts


508. Bone Marrow Failure: Acquired: Poster I  
Oral and Poster Abstracts


509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster I  
Oral and Poster Abstracts


625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


636. Myelodysplastic Syndromes: Basic and Translational: Poster I  
Oral and Poster Abstracts


637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster I  
Oral and Poster Abstracts


723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster I  
Oral and Poster Abstracts


903. Health Services and Quality Improvement: Myeloid Malignancies: Poster I  
Oral and Poster Abstracts


905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I  
Oral and Poster Abstracts


908. Outcomes Research: Myeloid Malignancies: Poster I  
Oral and Poster Abstracts


909. Education, Communication, and Workforce: Poster I  
Oral and Poster Abstracts

Sunday, December 8, 2024

top

9:00 AM-8:00 PM


Poster Session II - Viewing  
Events

9:30 AM-11:00 AM


509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Clinical and Translational Insights from Patients and Models  
Oral and Poster Abstracts

12:00 PM-1:30 PM


723. Allogeneic Transplantation: Long-Term Follow up and Disease Recurrence: Long-term Outcomes Including in Bone Marrow Failure and Rare Diseases  
Oral and Poster Abstracts

6:00 PM-8:00 PM


Poster Session II - Presentations (for in-person participants)  
Events


201. Granulocytes, Monocytes, and Macrophages: Poster II  
Oral and Poster Abstracts


508. Bone Marrow Failure: Acquired: Poster II  
Oral and Poster Abstracts


509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster II  
Oral and Poster Abstracts


602. Myeloid Oncogenesis: Basic: Poster II  
Oral and Poster Abstracts


618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster II  
Oral and Poster Abstracts


637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster II  
Oral and Poster Abstracts


722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster II  
Oral and Poster Abstracts


732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster II  
Oral and Poster Abstracts


901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II  
Oral and Poster Abstracts


905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II  
Oral and Poster Abstracts

Monday, December 9, 2024

top

9:00 AM-8:00 PM


Poster Session III - Viewing  
Events

10:30 AM-12:00 PM


732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Novel Approaches to Risk Stratification and Optimization for Transplant  
Oral and Poster Abstracts

12:15 PM-1:15 PM


A Different Option in the Treatment of Transfusion-Dependent Anemia in Lower-Risk MDS  
Product Theaters

2:45 PM-4:15 PM


506. Bone Marrow Microenvironment: The Bone Marrow Microenvironment in Disease  
Oral and Poster Abstracts

4:30 PM-6:00 PM


801. Gene Therapies: Gene Therapies for Hemophilia, Cancer and Immunodeficiencies  
Oral and Poster Abstracts


904. Outcomes Research: Hemoglobinopathies: Non-Malignant Conditions: Transforming Care: Insights into Healthcare Utilization, Outcome Measurement, and Treatment Impact in Sickle Cell Disease  
Oral and Poster Abstracts

6:00 PM-8:00 PM


Poster Session III - Presentations (for in-person participants)  
Events


101. Red Cells and Erythropoiesis, Excluding Iron: Poster III  
Oral and Poster Abstracts


503. Clonal Hematopoiesis, Aging, and Inflammation: Poster III  
Oral and Poster Abstracts


508. Bone Marrow Failure: Acquired: Poster III  
Oral and Poster Abstracts


509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster III  
Oral and Poster Abstracts


602. Myeloid Oncogenesis: Basic: Poster III  
Oral and Poster Abstracts


616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster III  
Oral and Poster Abstracts


618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster III  
Oral and Poster Abstracts


701. Experimental Transplantation: Basic and Translational: Poster III  
Oral and Poster Abstracts


721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster III  
Oral and Poster Abstracts


732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster III  
Oral and Poster Abstracts


802. Chemical Biology and Experimental Therapeutics: Poster III  
Oral and Poster Abstracts


803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster III  
Oral and Poster Abstracts


901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III  
Oral and Poster Abstracts


905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III  
Oral and Poster Abstracts